Literature DB >> 26984912

C2 Vertebral Fractures in the Medicare Population: Incidence, Outcomes, and Costs.

Adam M Pearson1, Brook I Martin2, Matthew Lindsey3, Sohail K Mirza2.   

Abstract

BACKGROUND: Cervical 2 (C2) fractures in the elderly are common, and the incidence of these fractures has been increasing. Surgical and nonoperative treatments are associated with high complication and mortality rates, and these rates have not been evaluated at the population level, to our knowledge. The purpose of this study was to use the Medicare claims database to determine trends in treatment, surgical and nonoperative outcomes, and Medicare reimbursement for treatment of these fractures.
METHODS: We examined the Medicare claims database from 2000 to 2011 to identify patients admitted for the treatment of a C2 fracture. The incidence of fractures and the rates of nonoperative and surgical treatment were determined across the study period. We compared rates of mortality and life-threatening complications between patients treated nonoperatively and surgically. Centers for Medicare & Medicaid Services (CMS) payments for the initial admission as well as for subsequent inpatient admissions during the ninety-day post-admission period were compared between treatment groups. We used multivariate analysis to control for differences in patient characteristics between groups.
RESULTS: There were 81,596 admissions for C2 fracture identified, and 53,338 met inclusion criteria. The incidence of C2 fractures increased 135% from 2000 to 2011, but the rate of surgical treatment remained constant at 16%. There was significantly lower mortality at thirty days for the surgical group at 8.3% compared with the nonoperative group at 16.2% (p < 0.001) and at one year for the surgical group at 21.7% compared with the nonoperative group at 32.3% (p < 0.001). Life-threatening complications within thirty days of admission were slightly more common in the surgical group at 10.9% compared with the nonoperative group at 9.0% (p < 0.05). Medicare reimbursements for the initial inpatient admission were significantly higher (p < 0.001) in U.S. dollars for the surgical group at $21,487 compared with the nonoperative group at $8469, and this significant difference (p < 0.001) persisted in the ninety-day post-discharge period at $10,487 for the surgical group compared with $8410 for the nonoperative group.
CONCLUSIONS: Although the incidence of C2 fractures in the Medicare population increased from 2000 to 2011, the rate of surgery stayed relatively constant. After controlling for baseline differences, patients treated with surgery had significantly lower thirty-day and one-year mortality rates compared with patients treated nonoperatively. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.

Entities:  

Mesh:

Year:  2016        PMID: 26984912     DOI: 10.2106/JBJS.O.00468

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

1.  Does fracture-extension into the pars interarticularis alter outcomes in odontoid failure? a technical note on pars interarticularis osteotomy and atlantoaxial distraction arthrodesis.

Authors:  Salvatore Russo; Reza Mobasheri; Felipe de Negreiros Nanni; Khai Lam
Journal:  Eur Spine J       Date:  2021-03-18       Impact factor: 3.134

Review 2.  Fractures of the axis: a review of pediatric, adult, and geriatric injuries.

Authors:  Megan E Gornet; Michael P Kelly
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

3.  C1-C2 Injury: Factors influencing mortality, outcome, and fracture healing.

Authors:  C Y Barrey; A di Bartolomeo; L Barresi; N Bronsard; J Allia; B Blondel; S Fuentes; B Nicot; V Challier; J Godard; P Marinho; P Kouyoumdjian; M Lleu; N Lonjon; E Freitas; J Berthiller; Y P Charles
Journal:  Eur Spine J       Date:  2021-02-26       Impact factor: 3.134

4.  Development and first application testing of a new protocol for CT-based stability evaluation of the injured upper cervical spine.

Authors:  Matthias K Jung; Lukas Hörnig; Michael M A Stübs; Paul A Grützner; Michael Kreinest
Journal:  Eur J Trauma Emerg Surg       Date:  2021-05-25       Impact factor: 3.693

5.  Characteristics and Management of Emergency Department Patients Presenting with C2 Cervical Spine Fractures.

Authors:  Allison Tadros; Melinda Sharon; Kristen Craig; William Krantz
Journal:  Biomed Res Int       Date:  2019-05-15       Impact factor: 3.411

6.  C2 Fractures in the Elderly: Single-Center Evaluation of Risk Factors for Mortality.

Authors:  Hoi-Ying H Chan; Frank A Segreto; Samantha R Horn; Cole Bortz; Godwin G Choy; Peter G Passias; Hamish H Deverall; Joseph F Baker
Journal:  Asian Spine J       Date:  2019-05-14

7.  C1-C2 fractures in asymptomatic elderly patients with minor head trauma: evaluation with a dedicated head CT protocol.

Authors:  Silvia Squarza; Carla Luisa Uggetti; Marco Angelo Politi; Lorenzo Carlo Pescatori; Raffaele Bisogno; Adriana Campi; Paolo Reganati; Maurizio Cariati
Journal:  Radiol Bras       Date:  2019 Jan-Feb

8.  Comparative Propensity-Weighted Mortality After Isolated Acute Traumatic Axis Fractures in Older Adults.

Authors:  Michael P Catalino; Virginia Pate; Til Stürmer; Deb A Bhowmick
Journal:  Geriatr Orthop Surg Rehabil       Date:  2020-03-30

9.  Predictors of 30-Day Unplanned Readmissions, Complications, and Mortality Following Operative Management of C2 Fractures.

Authors:  David N Bernstein; Caroline Thirukumaran; Brandon Raudenbush; Robert W Molinari; Emmanuel N Menga; Addisu Mesfin
Journal:  Global Spine J       Date:  2019-05-01

10.  Odontoid fractures: impact of age and comorbidities on surgical decision making.

Authors:  Syed Ali Mujtaba Rizvi; Eirik Helseth; Pål Rønning; Jalal Mirzamohammadi; Marianne Efskind Harr; Tor Brommeland; Mads Aarhus; Christina Teisner Høstmælingen; Håvard Ølstørn; Pål Nicolay Fougner Rydning; Magnus Mejlænder-Evjensvold; Nils Christian Utheim; Hege Linnerud
Journal:  BMC Surg       Date:  2020-10-14       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.